Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha | Patent Publication Number 20200369761

US 20200369761 A1
Patent NumberUS 11780911 B2
Application Number16880118
Filled DateMay 21, 2020
Priority DateMay 23, 2019
Publication DateNov 26, 2020
Original AssigneeJohnson & Johnson
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsMatthew Germinaro
Jacqueline Perrigoue
Mathew Germinaro
Christopher O'Brien
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.